Showing results (321-330 of 1,450) with videos related to
Sort By:
Pageof 145
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1987
Incidence of hip fractures in osteoporotic women treated with sodium fluorideB L Riggs, D J Baylink, M Kleerekoper, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1990
Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuriaR Pacifici, M Rothstein, L Rifas, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
Human bone cell phenotypes differ depending on their skeletal site of originC Kasperk, J Wergedal, D Strong, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1975
Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseasesShen F-H, D J Baylink, D J Sherrard, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 1, 1990
The causes of bone scintigram hot spots in fluoride-treated osteoporotic patientsE E Schulz, C Flowers, D D Sauser, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 1990
Effects of short term administration of recombinant human growth hormone to elderly peopleR Marcus, G Butterfield, L Holloway, et al.Endocrine Research Communications|January 1, 1979
Parathyroid hormone release is not associated with acute sympathetic arousal in goatsP R Marques, D D Williams, L Shen, et al.Clinical Chemistry|November 1, 1993
Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formationS G Linkhart, T A Linkhart, A K Taylor, et al.Endocrinology|March 1, 1989
Androgens directly stimulate proliferation of bone cells in vitroC H Kasperk, J E Wergedal, J R Farley, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1996
The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinuedJ R Talbot, M M Fischer, S M Farley, et al.Pageof 145